Description
Contents
Telmisartan
Indications/Uses
Essential HTN. Reduction of the risk of MI, stroke or death in patients β₯55 yr at high risk developing major CV events who are unable to take ACE inhibitors. High risk CV events including evidence of CAD, peripheral arterial disease, stroke, transient ischemic attack or diabetes w/ evidence of end-organ damage. Additional treatment to antihypertensive, antiplatelet or lipid-lowering therapy.
Dosage/Direction for Use
AdultΒ Essential HTNΒ 40 mg once daily, may be increased to max: 80 mg once daily.Β Severe HTNΒ 160 mg alone &/or in combination w/ hydrochlorothiazide 12.5-25 mg daily.Β CV risk reductionΒ 80 mg once daily.Β Mild to moderate hepatic impairmentΒ Not to exceed 40 mg once daily.
*The product images shown are for illustration purposes only and may not be an exact representation of the product.
